Poststroke Depression as a Factor Adversely Affecting the Level of Oxidative Damage to Plasma Proteins during a Brain Stroke by Cichoń, Natalia et al.
Research Article
Poststroke Depression as a Factor Adversely Affecting the Level
of Oxidative Damage to Plasma Proteins during a Brain Stroke
Natalia CichoN,1 MichaB Bijak,1 Elhbieta Miller,2,3 Marta Niwald,2,3 and Joanna Saluk1,4
1Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz,
Pomorska 141/143, 90-236 Lodz, Poland
2Department of Physical Medicine, Medical University of Lodz, Plac Hallera 1, 90-647 Lodz, Poland
3Neurorehabilitation Ward, III General Hospital in Lodz, Milionowa 14, 93-113 Lodz, Poland
4Department of Toxicology, Faculty of Pharmacy with Division of Medical Analytics, Wroclaw Medical University,
Borowska 211, 50-556 Wroclaw, Poland
Correspondence should be addressed to Marta Niwald; marta.niwald@umed.lodz.pl
Received 1 January 2015; Accepted 20 February 2015
Academic Editor: Tilman Grune
Copyright © 2015 Natalia Cichon´ et al.This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Poststroke depression, the second most serious psychosomatic complication after brain stroke, leads to delay of the rehabilitation
process and is associated with an increased disability and cognitive impairment along with increase in termmortality. Research into
the biochemical changes in depression is still insufficiently described. The aim of our study was therefore to evaluate the possible
association between plasma protein oxidative/nitrative damages and the development of poststroke depression. We evaluated
oxidative/nitrative modifications of specific proteins by measurement of 3-nitrotyrosine and carbonyl groups levels using ELISA
test. Additionally, we checked differences in proteins thiol groups by spectrophotometric assay based on reaction between DTNB
and thiols. We also evaluated catalase activity in erythrocytes measured as ability to decompose H
2
O
2
. Correlation analysis was
performed using Spearman’s rank. We observed significant (𝑃 < 0.001) differences in all oxidative/nitrative stress parameters in
brain stroke patients compared to healthy group. Our research shows that oxidative damage of proteins is correlated with the degree
of poststroke depression, while nitrative changes do not show any relationship. We demonstrate a positive correlation between the
concentration of carbonyl groups and the Geriatric Depression Scale and a negative correlation between the degree of depression
and the concentration of -SH groups or catalase activity.
1. Introduction
In the past few years, notable attention is paid to mental dis-
orders particularly prevalent among stroke patients, affecting
about one-third of population. Physical disability and psy-
chological stress occurring due to stroke need psychological
treatment conducted together with physical treatment and
rehabilitation [1]. Although affective disorders have not been
formally established as independent risk factor for stroke
and adverse prognostic factor responsible for impeding con-
valescing patients, attention to this physical/psychological
symptom has continued to increase in the past decade [2].
A growing body of evidence acknowledges the existence of
poststroke depression (PSD) [3].
Studies suggest that poststroke depression is the second
most serious psychosomatic complication after brain stroke.
Depression can occur at any stage after stroke (acute, suba-
cute, and chronic), although some authors classify this con-
dition as common mainly in the second phase of the disease
[4]. Poststroke depression is associated with an increased
disability and increased cognitive impairment and leads to
delay of the rehabilitation process, due to the deterioration of
motivation and low mood [5]. What is important in patients
with PSD appears to be 3-4-fold increase in short- and long-
term mortality compared with nondepressed patients [6].
However, research into the biochemical changes in
depression is still not systematized and is lacking in both
quality and quantity. Our aim in this study was therefore
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to evaluate the possible association between plasma protein
oxidative and nitrative damages and the development of PSD
in patients with acute ischemic stroke. In the past few years,
oxidative stress has received much notice with regard to
psychiatric illnesses including depression and it has been
proposed as a contributing factor in the pathogenesis of
depression [7]. Measurements of impaired redox balance
after the ischemic stroke occurrence might be useful to
monitor the outcome of patients who suffered an ischemic
stroke in terms of stroke recurrence and other vascular
events. This is particularly important for patients whose
convalescence may be slowed down due to the presence of
PSD.
Oxidative stress is thought to be a contributing factor in
many chronic neurodegenerative pathologies, as well as acute
cerebrovascular disorders such as stroke. The pathogenesis
of acute ischemic stroke is highly complex and embroils
multiple mechanisms. It is well proven that oxidative stress
is involved in the pathogenesis of acute ischemic stroke. In
ischemic stroke, blood flow is interrupted to a portion of
the brain by a formation of clot blocking an artery. The
later reperfusion of the engaged brain area when blood flow
is restored is associated with a rapid increase in oxidative
damage. Imbalance between the cellular production of free
radicals and the ability of cells to defend against them is one of
key mechanisms contributing to neuronal damage [8]. These
conditions support oxidative and nitrative modifications in
some amino acids. Proteins constitute one of themajor targets
of ROS/RNS (reactive oxygen/nitrogen species). Oxidative
and nitrative changes in proteins include carbonyl groups
formation, oxidation of the thiol groups and nitrotyrosine (3-
NT) generation [9].
Some neurological disorders, including stroke, are asso-
ciated with oxidative and nitrative modification of specific
proteins and the accumulation of oxidative damage. There
are several evidences that markedly indicate involvement
of oxidative and nitrative stress in the pathophysiology
of depression [10, 11]. Increased levels of ROS and RNS
in depression, mainly peroxide [10] and NO [12, 13], and
decreased levels of antioxidants, such as glutathione (GSH),
in the postmortem depression brain have been demonstrated
[14]. For this reason, oxidative and nitrativemechanisms have
been proposed as targets for novel antidepressants [15].
Oxidative stress leads to inactivation and modification of
antioxidant enzymes and weakening of antioxidant defense.
The oxidation of proteins can be responsible for their conver-
sion to forms more susceptible to degradation by proteinases
[8, 16]. Protein carbonyl formation is an index of oxidative
stress, as a result of amino acid modifications. Carbonylation
of proteins is a nonenzymatic addition of aldehydes or
ketones to specific amino acid residues, mainly to arginine,
lysine, threonine, proline, cysteine, or histidine [17].
Shifts of redox-equilibrium in thiol-disulfide plasma sys-
tem are implicated as a key mechanism of oxidative damage
and restoration of redox homeostasis in postacute stroke
patients. ROS-dependent oxidative modification of redox
active cysteines within proteins is responsible for regula-
tion of activity of a variety of protein functions, including
enzyme activity, protein expression and abundance, protein
localization, and interaction with other biomolecules in con-
trolling of cell signaling and gene expression [18]. Oxidized
cysteine residues can react with nitric oxide (NO) to form
a nitrosothiol or with another protein thiol group to give a
disulfide bond [19].
The nitrative stress can promote nitrosative posttransla-
tional modifications of proteins that are implicated in the
pathogenesis of the associated cardiovascular dysfunction
[20, 21]. However, simultaneous formation of nitric oxide
and superoxide radicalsmay reduce S-nitrosylation of protein
due to concurrently generating the potent tyrosine-nitrating
agent peroxynitrite (ONOO−). Protein nitration and accu-
mulation of 3-nitrotyrosine is a biomarker of nitrative stress
induced by peroxynitrite and other reactive nitrogen species.
Tyrosine nitration as an usual modification is also a relatively
specific marker of oxidative damage mediated by ONOO−,
which is formed by the reaction of superoxide with nitric
oxide and is important for the regulation of protein structure
and function [22].
The antioxidant defense system in the organism com-
prises enzymatic and nonenzymatic components. In the
pathogenesis of acute ischemic stroke low molecular antiox-
idants are consumed in the reaction with free radicals
generated during the oxidative stress. The endogenous cat-
alytic system includes a variety of antioxidant enzymes
such as superoxide dismutase (SOD), catalase (CAT), and
glutathione peroxidase. Among them, the first line of defense
is a catalase which decomposes hydrogen peroxide, since
its accumulation can lead to the formation of free radicals
[23, 24]. The body of evidence suggests that depression
belongs to the spectrum of (neuro)degenerative disorders
and is accompanied by a decreased antioxidant status and by
induction of oxidative and nitrative pathways. A significant
association between depression and polymorphisms in genes
involved in oxidative and nitrative pathways, like manganese
superoxide dismutase, catalase, and myeloperoxidase, is also
known [10].
In our study we compare the activities of CAT in the
erythrocytes of PSD patients and nondepression patients.
Our study was aimed to investigate the dynamic of some
oxidative and nitrative markers of plasma proteins during the
convalescent of postacute stroke patients with depression.
2. Materials and Methods
2.1. Chemicals. Anti-dinitrophenyl (DNP) antibodies devel-
oped in rabbit, bicinchoninic acid protein assay kit, o-
phenylenediamine dihydrochloride (OPD peroxidase sub-
strate), and DNTB (5,5󸀠-dithiobis(2-nitrobenzoic acid)) were
purchased from Sigma-Aldrich (St. Louis, MO, USA). 2,4-
Dinitrophenylhydrazine (DNPH) was obtained from Polish
Chemical Reagents (POCH, Gliwice). All other reagents
were of analytical grade and were provided by commercial
suppliers.
2.2. Patients. 35 patients following ischemic stroke were
enrolled for the study and 29 poststroke patients were
carefully selected who met inclusion criteria and did not
meet any criterion for exclusion. A total of 35 patients (aged
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Table 1: Clinical demographic characteristics. ADL: activity daily
living; BMI: body mass index; GDS: Geriatric Depression Scale;
NIHSS: National Institutes of Health Stroke Scale; NSAID: nons-
teroidal anti-inflammatory; ASA: acetylsalicylic acid.
GDS < 11
(non-D)
𝑛 = 6
GDS ≥ 11 (D)
𝑛 = 29
Healthy
𝑛 = 20
Demographics
Age (mean ± SD) 70.0 ± 14.6 74.3 ± 16.3 53.9 ± 10.6
Sex (% male) 66.7 47.2 25.6
Living alone (%) 48.2 56.7 33.8
Vascular risk
Hypertension (%) 92.6 97.9
Diabetes (%) 20.3 27.8
Dyslipidemia (%) 65.8 76.8
BMI ≥ 30 (%) 16.8 27.9
Concomitant medications
Antidepressants (%) 3.4 23.7
ASA 62.8 78.8
NSAID 8.7 20.8
Stroke characteristics
Weeks since stroke
(mean ± SD) 5.3 ± 3.7 5.6 ± 4.2
NIHSS scores mean ±
SD 5.2 ± 4.7 5.8 ± 3.5
ADL mean ± SD 11 ± 5.6 10.7 ± 6.7
Lesion location
Anterior (%) 12.0 15.8
Posterior (%) 52.6 36.7
Intermediate (%) 12.0 27.0
Lesion side
Left (%) 56.7 58.4
Right (%) 43.3 41.6
74.3±16.3) withmoderate stroke severity (NIHSS scores 5.8±
3.5) who agreed to participate were included in this analysis.
29 patients were screened for positive results for depressive
symptoms (GDS ≥ 11). Subjects with and without depressive
symptoms were similar in demographics and clinical charac-
teristics (Table 1). Patients with amedical history of prestroke
dementia, hemorrhagic stroke, decreased consciousness, sig-
nificant acute or chronic inflammatory factor or neurological
illness other than stroke, and psychiatric disorder other
than depression were excluded. All blood samples (control
groups and patients) were taken in the morning (between
7 am to 9 am) in fasting status and stored using the same
protocol.Theprotocol was approved by the Ethics Committee
of the Faculty of Biology and Environmental Protection of
University of Lodz, Poland number 16/2013. All participants
provided written informed consent prior to participation.
Depression was screened using the Geriatric Depression
Scale (GDS) on which a score ≥11 is a reliable and sensitive
indicator of poststroke depression [13]. A trained psycholo-
gist researcher administered the GDS scale. The GDS, ADL,
and NIHSS were administered either on the same day as the
blood draw or on the afternoon before.
2.3. Determination of Protein Carbonyl Groups in Human
Blood Plasma by ELISA Method. The detection of protein
carbonyl groups was performed in human blood plasma
using ELISA method described by Buss et al. [25] and
modified by Alamdari et al. [26]. The microplates were
incubated overnight at 4∘C where plasma proteins were
nonspecifically adsorbed onto ELISA plates. The wells were
washed 3 times with 300𝜇L PBS, reacted with dinitrophenyl-
hydrazine (DNPH; 0.05mM, 200 𝜇L, pH 6.2), incubated for
45min at room temperature in the dark, and washed 5 times
with 300𝜇LPBS: ethanol (1 : 1, v/v) and a last timewith 300𝜇L
PBS, all in accordance with Alamdari et al. [26]. Carbonyl
groups were detected by anti-DNP antibodies (I step) and
then a second antibody conjugated with horseradish per-
oxidase was added for quantification (II step) according to
Alamdari et al. [26] procedure. This sensitive method was
calibrated using oxidized albumin and required only 5 𝜇g
protein per well. The standard curve was linear in the range
of 0–3.36 nmol carbonyls/mg albumin [27].
2.4. Determination of Thiol Groups. Thiol groups in blood
plasma proteins were determined using 5,5󸀠-dithio-bis(2-
nitro-benzoic acid) (Ellman’s reagent, DTNB) [28].The thiol-
disulfide interchange reaction between DTNB and thiol is
the basis of this spectrophotometric assay. The samples were
mixed with DTNB and at the end of the incubation (1 h,
37∘C) period the absorbances were recorded at 412 nm. The
concentrations were calculated by using 𝜀 = 13600M−1 cm−1
and the results were expressed as 𝜇mol/L.
2.5. Determination of 3-Nitrotyrosine in Plasma Proteins by
the Competitive ELISA Test. The detection of 3-nitrotyrosine
in blood plasma was performed according to the method
described by Khan et al. [29] and was modified as was
described previously [27]. The concentrations of nitrated
plasma proteins were estimated from the standard curve,
constructed with the use of 3-nitrotyrosine-containing fib-
rinogen (3-NT-Fg). 3-NT-Fg was prepared by the exposure
of human fibrinogen to 1000 𝜇M peroxynitrite action. The
presence of 3-nitrotyrosine in fibrinogenwas confirmed spec-
trophotometrically at 302 nm, at pH 11.5 (molar absorption
coefficient for nitrotyrosine, 𝜀 = 4400M−1× cm−1) [30], and
then the obtained nitro-fibrinogen was used for the prepara-
tion of the standard curve, ranging from 10 to 1000 nmol/L of
3-nitrotyrosine-fibrinogen equivalent.
2.6. Catalase Activity Estimation. Catalase activity in ery-
throcytes was estimated spectrophotometrically using Beers
and Sizer method [31]. Changes in absorbance were recorded
at 240 nm. CAT activity was calculated in terms of nM
H
2
O
2
consumed/min using molar extinction coefficient 𝜀 =
36000M−1 cm−1 and shows as Bergmeyer unit [32].
2.7. Statistical Analysis. Thestatistical analysiswas performed
using StatsDirect statistical software V. 2.7.2. All values in
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Figure 1: Differences of carbonyl group levels between stroke
patients and control group. Carbonyl group level was measured in
plasma proteins by ELISA method, 𝑛 = 31, 𝑃 < 0.0001.
this study were expressed as mean ± SD. The obtained
results were analyzed under the account of normality with
Shapiro-Wilk test. The significance of differences between
the values was analyzed depending on the normality by
unpaired t-Student or U-Mann-Whitney tests. Correlation
analysis between obtained numerical data was performed
using Spearman’s rank correlation [33]. A level of 𝑃 < 0.05
was accepted as statistically significant.
3. Results
In our study we determined organism oxidative and nitrative
stress parameters in stroke patients, especially in patients
with poststroke depression. A comparative analysis shows
that oxidative and nitrative stress parameters are significantly
higher in stroke patients (both patients with PSD and nonde-
pression patients) than in control groups (healthy people). All
measured parameters were changed in stroke group (Figures
1–4). We observed a statistically significant increased level of
carbonyl groups in plasma proteins (Figure 1), decreased level
of plasma protein thiol groups (Figure 2), decreased catalase
activity in erythrocytes (Figure 3), and increased plasma
protein 3-nitrotyrosine level (Figure 4) in stroke patients in
relation to control group. In the case of carbonyl groups
and 3-nitrotyrosine, the observed increase in oxidative and
nitrative protein damage after strokewasmore than two times
higher in patients than in controls (Figures 1 and 4).
Additionally, we observed dependence between changes
in oxidative and nitrative stress parameters and poststroke
depression intensity measured by Geriatric Depression Scale
(GDS). As the distribution of the results of the GDS deviates
from the normal, the method of Spearman correlation was
more suitable for use in these analyzes. Obtained correla-
tion parameters (Table 2) indicate the significant positive
correlation between carbonyl group level and GDS, whereas
between thiol group concentration/catalase activity and GDS
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Figure 2: Differences of thiol group levels between stroke patients
and control group. The concentration of thiol groups was measured
in plasma proteins using Ellman’s reagent, 𝑛 = 31, 𝑃 < 0.0001.
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
Control Brain stroke
3-NT
0.27
0.58
(n
m
ol
/m
g 
of
 p
la
sm
a p
ro
te
in
s)
Figure 3: Differences of 3-nitrotyrosine levels between stroke
patients and control group. 3-Nitrotyrosine level was measured in
plasma proteins by c-ELISA method, 𝑛 = 22, 𝑃 < 0.0001.
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Figure 4: Differences of catalase activity between stroke patients
and control group. Catalase activity was measured in erythrocytes
using H
2
O
2
disproportionation method, 𝑛 = 35, 𝑃 < 0.0001.
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Table 2: Correlation coefficients values obtained for oxidative stress parameters and Geriatric Depression Scale. Correlation was analyzed
using Spearman’s rank correlation method and probability for correlation was presented in parentheses.
Carbonyl groups Thiol groups Catalase activity 3-Nitrotyrosine
Spearman’s rank correlation
coefficient (Rho)
0.578941
(𝑃 = 0.0014)
−0.519103
(𝑃 = 0.0073)
−0.57903
(𝑃 = 0.0028)
0.071829
(𝑃 = 0.754)
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Figure 5: Regression plots of selected parameters of oxidative stress in patients with poststroke depression and GDS. (a) Plot for correlation
between carbonyl group level and GDS; (b) plot for correlation between thiol group level and GDS; (c) plot for correlation between catalase
activity and GDS.
we observed a significant negative correlation. For nitrative
stress the marker which is a 3-nitrotyrosine showed no cor-
relation with GDS. For dependence of carbonyl group level
(Figure 5(a)), thiol groups level (Figure 5(b)), catalase activity
(Figure 5(c)), and GDS regression plots were determined.We
have shown the detailed course of these correlations, which
confirms correlation and received numeric data presented in
Table 2.
4. Discussion
Thedevelopment of poststroke depression is a frequentmood
disorder that affects around one-third of stroke patients; how-
ever, the etiology of PSD is not well understood. Probably,
both the psychosocial and biological factors are significant in
the development of poststroke depression [34].
Previous studies have identified relationships between
PSD and increased functional disability [35, 36]. In the
last studies poststroke depression was also associated with
inflammation [37]. Previous studies have reported the ele-
vated levels of some inflammatory mediators in PSD, includ-
ing IL-18, [38, 39], C-reactive protein [40, 41], and IL-17which
is able to disrupt the blood brain barrier and contribute to
neurodegeneration through increased production of reactive
oxygen species [42, 43].
The brain with its high oxygen consumption and a
lipid-rich environment is considered highly susceptible to
oxidative stress or redox imbalances. Therefore, it is very
probable that oxidative stress is implicated in several mental
disorders, including depression. Although some studies have
established a link between oxidative stress and psychiatric
disorders, the causal relationship between them is not fully
determined. Several mechanisms including genetic predis-
position, abnormalities in traditional signal transduction
pathways, and oxidative stress theory have been proposed
to be involved in depression pathogenesis [7, 44, 45]. It
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has been demonstrated that depression in medically healthy
patients has been associated with increased concentrations
of blood cytokines [46], elevated levels of ROS and RNS
[10–13], and increased F2 isoprostane excretion [47]. More-
over, considerably lower plasma concentrations of several
key antioxidants, such as vitamin E, zinc, and coenzyme
Q10, and reduced antioxidant enzyme activity, as well as
reduced level of brain GSH, have been reported in major
depression [10, 14]. The existence of a possible link between
depression and central nervous system (CNS) inflammation
is suggested in a few recent papers on the neuroimmunology
of stroke [48, 49]. The mechanisms related with PSD may
involve an imbalance between proinflammatory and anti-
inflammatory activity responsible for augmenting of oxida-
tive stress, whichmay weaken cognitive susceptibility. Recent
studies demonstrate that oxidative and nitrative stress may
contribute to the pathogenesis of depression through partic-
ipation in neurogenesis/neuroplasticity, neuroinflammation,
and monoamine reuptake process [50, 51]. Recent trend is
that antidepressants exert a therapeutic effect by suppressing
the production of inflammatory cytokines and ROS/RNS
or increasing the antioxidant defense [15]. Therefore, inhi-
bition of inflammation and concomitant oxidative stress
may possibly contribute to the improvement of mental and
physical efficiency of stroke patients. However, research into
the changes and oxidative damage to major biomolecules in
depression still lacks in both quality and quantity. Although
the depression is one of the many consequences of stroke,
it is still poorly diagnosed and inadequately treated [52].
Accordingly, these studies place particular emphasis on the
examination of biochemical parameters that may directly
affect the improvement of the functionality of patients
depending on the severity of their depression.
Brain ischemia initiates a complex cascade of metabolic
events, and most of them involve the generation of nitro-
gen and oxygen free radicals. Oxidative stress, associated
with inflammation or postischemic reperfusion, may lead
to oxidative and nitrative modifications of protein structure,
leading to the alterations in their functional properties, and
may cause accumulation of modified protein products, that
has been observed under various conditions, such as aging,
cell differentiation, and apoptosis [53].The increase of oxida-
tive stress parameters during a stroke is well documented
in the literature. Oxidative stress plays a significant role in
the damage associated with ischemic cascade arising from
reperfusion, which is restoration of blood flow in the blood
vessel after the hypoxia. Oxidative stress which occurs during
a stroke significantly affects the irreversible neuronal damage
[54–57]. After ischemia-reperfusion ROS may be generated
from many sources, including an increased oxidation of
catecholamines and hemoglobin, associated with a massive
release of iron ions. Furthermore, ROS are produced due to
changes in the mitochondrial electron transport, the acti-
vation of xanthine oxidoreductase and NAD(P)H oxidase,
and during the metabolism of arachidonic acid [58]. As a
result of hypoxia, a brain tissue is depleted of oxygen and
glucose which are essential products for the ATP synthesis.
Thus, it inhibits the activity of sodium-potassium pump and
causes an inflow of calcium ions into the cell. Increased
concentration of Ca2+ in the cell leads to the activation of
Ca2+-dependent enzymes, including proteases and nucleases
that are responsible for degradation processes of neurons
[59].
Based on the above facts, the present study has been
designed to explore the possible relationship between the
level of typical markers of oxidative and nitrative protein
modifications (carbonyl groups, 3-NT, SH-groups, CAT-
activity) and the degree of poststroke depression. Oxidation
of amino acid residues leads to the formation of relatively
stable carbonyl groups that can be qualitative and quantitative
markers enabling the assessment of the oxidative damage
of proteins [60, 61]. In our studies, oxidative damage of
proteins has been documented as an increased concentration
of carbonyl groups in plasma proteins in patients after cere-
bral ischemia-reperfusion injury (Figure 1). Furthermore, a
significant positive correlation between the level of carbony-
lation and Geriatric Depression Scale (GDS) has also been
seen (Figure 5(a)). We have demonstrated more than twofold
increase in protein carbonyl groups in poststroke patients
as compared to healthy subjects. Our findings are consistent
with previous reports. Wang et al. showed a significantly
higher increasing the amount of carbonyl groups in the
brain tissue of rats with hypoxia-induced brain damage [62].
The link between free radical generation and formation of
carbonyl groups in protein molecules in different patholog-
ical conditions, including stroke [7], is well documented.
However, our findings demonstrate for the first time a
significant correlation between the degree of oxidation of the
amino acid residues in plasma proteins and the GDS in post
stroke patients.
The most important barrier that protects the brain tissue
from damage is the blood-brain barrier (BBB). Particular role
played the integrity of monolayer of brain capillary endothe-
lial cells. Glutathione is low molecular weight antioxidant
that protects endothelial cells from oxidative damage and
affects the regeneration process after oxidative damage of cells
occurring during a stroke [18]. Moreover, thiol compounds
are the first line of defense against ROS and increasing of
their oxidation is marker of oxidative stress [63]. Regulation
of protein function through thiol-based redox switches plays
an important role in maintaining redox homeostasis. Our
study showed that concentration of thiol groups in plasma
proteins in poststroke patients is approximately 20% lower
than in the control group of healthy subjects (Figure 2).
Analogous results are obtained by Tsai et al. and Wang et
al. who studied the relationship between oxidative stress and
the occurrence of other side effects in patients with acute
stroke [64, 65]. Moreover, Tsai et al. postulated that the level
of free thiol groups was significantly lower in patients with
large-vessel disease than in those with small-vessel disease
in the acute phase of stroke [64]. This proves that the level
of free thiol groups depends on the extent of brain damage
caused by oxidative stress, while our studies indicate that the
degree of the thiol group oxidation in the plasma proteins
is dependent on depression scale in poststroke patients. A
significant negative correlation is indicated in Figure 5(b).
Protein nitration process resulting in the formation of 3-
nitrotyrosine is mainly caused by strong biological oxidant
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peroxynitrite (PN) [66]. PN is a potent oxidant and nitrating
compound, generated in vivo from the rapid reaction of two
relatively less reactive but commonly found of free radicals:
nitrogen monoxide (∙NO) and superoxide (O
2
∙−) [8]. Nitric
oxide, a water- and lipid-soluble free radical, is generated
by the action of nitric oxide synthases. Besides synthesis
of nitric oxide, cerebral ischemia leads to the formation of
the anion, mainly by the action of nitric oxide synthase,
xanthine oxidase, and leakage of mitochondrial electron
transport chain. There is increasing evidence that at high
concentrations PN is the major compound responsible for
ischemia-reperfusion injury or tissue damage by inflamma-
tion [67–71]. Ischemic stroke is an acute vascular event that
obstructs blood supply to the brain and causes irreversible
damage to both neurons and brain vessel cells. Immediately
after the stroke, the ischemic tissue produces nitric oxide
to restore blood perfusion but also produces superoxide
anion. The interaction of these reactive species leads to
the formation of peroxynitrite, which irreversibly nitrates
protein tyrosines. Recent studies have emphasized the role of
peroxynitrite in vascular damages. Increased 3-nitrotyrosine
level was observed in various cardiovascular diseases [72].
Vadseth et al. reported the augmented level of nitrated tyro-
sine residues in plasma proteins derived from patients with
coronary artery disease [73]. Bas et al. have demonstrated a
significant increase in the concentration of 3-NT positively
correlated with elevated activity of metalloproteinases activ-
ity (MMPs) in patients after ischemic stroke [74]. Similarly,
increased concentration of NT-3 was observed in the studies
Coucha et al. who investigated effect of neuronal damage
during a stroke on the reactivity of cerebral vessels in rat.They
confirmed the hypothesis that the loss of tone of blood vessel
was affected by excessive production of peroxynitrite. On
this basis, the authors postulated that ischemia-reperfusion
injury impairs vessel reactivity via nitration [75]. Moreover,
Tajes et al. who studied the effects of PN on the viability of
the different brain cells also reported an important role of
nitrooxidative stress in the pathogenesis of ischemic stroke
[76]. Our studies have shown that the concentration of 3-
nitrotyrosine in plasma proteins was approximately twice
higher in poststroke patients in comparison with healthy
controls (Figure 3). However, unlike in the case of oxidative
stress, no relationship was found between protein nitrative
damage and Geriatric Depression Scale.
Superoxide anion in addition to the formation of perox-
ynitrite is involved in a range of toxic mechanisms leading
to tissue damage. The production of radicals in the brain
is due to catecholamine metabolism such as dopamine and
norepinephrine and is increased by the presence of transition
metals and by a deficiency of antioxidant agents. Due to the
high toxicity of free radicals the organism has developed a
number of specialized and efficient methods to deactivate
them. The superoxide dismutase enzyme (SOD) catalyzes a
dismutation of the superoxide radical into hydrogen peroxide
and oxygen. Afterwards hydrogen peroxide is reduced to
water and molecular oxygen by peroxidase glutathione and
catalase enzymes [77]. Catalase is not directly involved in the
elimination of ROS but does not allow for Fenton’s reaction
to take place in which hydrogen peroxide is converted to
highly toxic hydroxyl radicals. Following ischemia there is
an increased enzymatic production of ROS, especially super-
oxide anion and hydrogen peroxide in a reaction catalyzed
by xanthine oxidase. During reperfusion molecular oxygen
is delivered and xanthine oxidase converts the hypoxanthine
to xanthine. In such conditions superoxide anion is released
in large quantities. It provides the opportunity for the
production of hydrogen peroxide and consequently highly
toxic hydroxyl radicals [59]. According to the literature, in
stroke, the SOD value does not vary, while the CAT value
decreases [77]. Reduced activity of catalase in stroke patients
diminishes the effectiveness of deactivation of H
2
O
2
[78],
which can freely diffuse across the mitochondrial membrane,
and therefore increases oxidative stress. In our study we
noticed that that catalase activity in erythrocytes of stroke
patients was about 25% lower in comparison with a control
group of healthy (Figure 4). The similar effect of reduction
in CAT activity in stroke-induced rats was also observed
in studies conducted by Safwen et al. [54]. However, our
studies have showed that decrease in the activity of catalase
is dependent on Geriatric Depression Scale in poststroke
patients. A significant negative correlation is indicated in
Figure 5(c).
In conclusion, oxidative and nitrative stress parameters
have been seen in the present study. However, only oxidative
damage of proteins seems to be correlated with the degree
of poststroke depression, while nitration of proteins did not
show such a relationship. This indicates that the strategies
attenuating oxidative stress in poststroke patients can be eval-
uated for efficacy as novel antidepressants in this population.
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